Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.

Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.

BACKGROUND: Somatic mutations in phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) are frequent in breast tumours and have been associated with oestrogen receptor (ER) expression, human epidermal growth factor receptor-2 overexpression, lymph node metastasis and poor survival. The goal of...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Stevens, K, Garcia-Closas, M, Fredericksen, Z, Kosel, M, Pankratz, V, Hopper, J, Dite, G, Apicella, C, Southey, M, Schmidt, M, Broeks, A, Van 't Veer, L, Tollenaar, R, Fasching, P, Beckmann, M, Hein, A, Ekici, AB, Johnson, N, Peto, J, dos Santos Silva, I, Gibson, L, Sawyer, E, Tomlinson, I, Kerin, M, Chanock, S
Format:	Journal article
Język:	English
Wydane:	2011

Podobne zapisy

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
od: Figueroa, J, i wsp.
Wydane: (2011)

9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.
od: Warren, H, i wsp.
Wydane: (2012)

11q13 is a susceptibility locus for hormone receptor positive breast cancer
od: Lambrechts, D, i wsp.
Wydane: (2012)

11q13 is a susceptibility locus for hormone receptor positive breast cancer.
od: Lambrechts, D, i wsp.
Wydane: (2012)

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.
od: Lin, W, i wsp.
Wydane: (2015)

Phosphoinositide Profile of the Mouse Retina
od: Stella Finkelstein, i wsp.
Wydane: (2020-06-01)

Phosphoinositides in the kidney
od: Leopoldo Staiano, i wsp.
Wydane: (2019-02-01)

Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases
od: Gillian L. Dornan, i wsp.
Wydane: (2018-03-01)

Phosphoinositide Lipids in Ocular Tissues
od: Ammaji Rajala, i wsp.
Wydane: (2020-06-01)

Phosphoinositides in Retinal Function and Disease
od: Theodore G. Wensel
Wydane: (2020-04-01)

Thin-layer chromatography of the phosphoinositides
od: F. Gonzalez-Sastre, i wsp.
Wydane: (1968-07-01)

Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome
od: Alison M. Condliffe, i wsp.
Wydane: (2018-03-01)

Spatial regulation of membrane fusion controlled by modification of phosphoinositides.
od: Fabrice Dumas, i wsp.
Wydane: (2010-01-01)

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
od: Meyer, K, i wsp.
Wydane: (2013)

Phosphoinositides and intracellular calcium signaling: novel insights into phosphoinositides and calcium coupling as negative regulators of cellular signaling
od: Byung-Chul Oh
Wydane: (2023-08-01)

A mathematical model of the phosphoinositide pathway
od: Olivença, DV, i wsp.
Wydane: (2018)

Phosphoinositide signalling in inflammation and colorectal cancer
od: Osborne, C, i wsp.
Wydane: (2003)

Phosphoinositide signalling in inflammation and colorectal cancer
od: Osborne, C, i wsp.
Wydane: (2003)

Phosphoinositides Coated Beads Binding Assay
od: Manuel Gálvez-Santisteban, i wsp.
Wydane: (2014-02-01)

Phosphoinositide Signaling in Immune Cell Migration
od: Ruchi Kakar, i wsp.
Wydane: (2023-11-01)

Regulation of phosphoinositide metabolism in Apicomplexan parasites
od: Angela Arabiotorre, i wsp.
Wydane: (2023-09-01)

Participation of the phosphoinositide metabolism in the hypersensitive response of Citrus limon against Alternaria alternata
od: XIMENA ORTEGA, i wsp.
Wydane: (2001-01-01)

Deleterious Variants of FIG4, a Phosphoinositide Phosphatase, in Patients with ALS
od: Chow, Clement Y., i wsp.
Wydane: (2015)

Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
od: Xueqin Huang, i wsp.
Wydane: (2023-12-01)

Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of <it>BRCA1 </it>and <it>BRCA2 </it>deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age
od: Turkovic Lidija, i wsp.
Wydane: (2010-09-01)

Oncogenes /
od: 311669 Cooper, Geoffrey M.
Wydane: (1995)

3-Phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer
od: Fyffe C, i wsp.
Wydane: (2013-08-01)

Liposome Flotation Assays for Phosphoinositide-protein Interaction
od: Helene Tronchere, i wsp.
Wydane: (2017-03-01)

Regulation of the Phosphoinositide Code by Phosphorylation of Membrane Readers
od: Troy A. Kervin, i wsp.
Wydane: (2021-05-01)

Nuclear Phosphoinositides as Key Determinants of Nuclear Functions
od: Magdalena C. Vidalle, i wsp.
Wydane: (2023-06-01)

Regulation of Phosphoinositide Signaling by Scaffolds at Cytoplasmic Membranes
od: Tianmu Wen, i wsp.
Wydane: (2023-08-01)

Phosphoinositides in plant-pathogen interaction: trends and perspectives
od: Fauzia Zarreen, i wsp.
Wydane: (2023-04-01)

Nuclear Phosphoinositides—Versatile Regulators of Genome Functions
od: Enrique Castano, i wsp.
Wydane: (2019-06-01)

Phosphoinositides in the Hepatitis C Virus Life Cycle
od: Aleem Siddiqui, i wsp.
Wydane: (2012-10-01)

The expanding spectrum of neurological disorders of phosphoinositide metabolism
od: Jonathan R. Volpatti, i wsp.
Wydane: (2019-08-01)

Phosphoinositide Signaling and Mechanotransduction in Cardiovascular Biology and Disease
od: Amanda Krajnik, i wsp.
Wydane: (2020-12-01)

Phosphoinositide 3-kinase: a critical signalling event in pulmonary cells
od: Cowburn Andrew S, i wsp.
Wydane: (2000-06-01)

Targeting phosphoinositide signaling in cancer: relevant techniques to study lipids and novel avenues for therapeutic intervention
od: Alicia Llorente, i wsp.
Wydane: (2023-10-01)

Expression of phosphoinositide-specific phospholipase C isoforms in native endothelial cells.
od: Delphine M Béziau, i wsp.
Wydane: (2015-01-01)

Signaling through non-membrane nuclear phosphoinositide binding proteins in human health and disease
od: Jamal M. Bryant, i wsp.
Wydane: (2019-02-01)